Tarlatamab: the promising immunotherapy on its way from the lab to the clinic is a research paper published in Translational Lung Cancer Research (2023). On theSindex it has a DataRank of 0. It has been cited 10 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: 5R01CA160417-09
Mitophagy in Tumor Microenvironment
National Institutes of Health
Grant: 5R01CA229275-05
Mechanisms of Ferroptotic Cancer Cell Death
National Institutes of Health
Grant: 5R01CA211070-02
The Pancreatic Cancer Microenvironment
FWCI
1.14
Citation Percentile
0.8%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals